Shares of Afya Limited (NASDAQ:AFYA – Get Free Report) have been given a consensus recommendation of “Moderate Buy” by the six ratings firms that are presently covering the company, Marketbeat reports. Three investment analysts have rated the stock with a hold rating and three have issued a buy rating on the company. The average 1-year price objective among analysts that have issued ratings on the stock in the last year is $18.75.
Several brokerages have recently issued reports on AFYA. Wall Street Zen downgraded Afya from a “strong-buy” rating to a “buy” rating in a research report on Saturday. UBS Group raised Afya from a “neutral” rating to a “buy” rating and lowered their target price for the company from $19.50 to $19.00 in a report on Monday, September 8th. JPMorgan Chase & Co. raised Afya from a “neutral” rating to an “overweight” rating and increased their price objective for the company from $23.50 to $24.50 in a research report on Monday, September 8th. Finally, Weiss Ratings reiterated a “hold (c)” rating on shares of Afya in a research note on Wednesday, October 8th.
Read Our Latest Research Report on Afya
Afya Stock Performance
Institutional Investors Weigh In On Afya
Several hedge funds have recently made changes to their positions in the stock. Doma Perpetual Capital Management LLC boosted its stake in Afya by 50.6% in the 3rd quarter. Doma Perpetual Capital Management LLC now owns 891,639 shares of the company’s stock valued at $13,910,000 after buying an additional 299,419 shares in the last quarter. SPX Gestao de Recursos Ltda bought a new position in shares of Afya during the third quarter valued at $2,895,000. Perpetual Ltd boosted its stake in shares of Afya by 1.8% in the 2nd quarter. Perpetual Ltd now owns 151,180 shares of the company’s stock valued at $2,700,000 after purchasing an additional 2,730 shares in the last quarter. Carrera Capital Advisors bought a new stake in shares of Afya in the 2nd quarter worth about $1,750,000. Finally, GSA Capital Partners LLP increased its position in shares of Afya by 45.5% during the 3rd quarter. GSA Capital Partners LLP now owns 89,747 shares of the company’s stock worth $1,400,000 after purchasing an additional 28,053 shares in the last quarter. Institutional investors own 88.02% of the company’s stock.
About Afya
Afya Ltd. operates as a leading provider of medical education and training services in Brazil. The company offers a comprehensive suite of educational programs that span undergraduate medical degrees, residency exam preparation, continuing medical education (CME) and digital learning platforms. Through a network of partner institutions and its own campus operations, Afya supports students at every stage of the medical training continuum, from enrollment in medical schools to ongoing professional development for practicing physicians.
At the core of Afya’s offerings is its undergraduate medical program, delivered through a combination of in-person courses at affiliated campuses and fully digital curricula.
Recommended Stories
- Five stocks we like better than Afya
- The boring AI play that could pay up to $4,290 monthly
- Put $1,000 into this stock by Jan 1 [Not NVDA]
- Trump’s “real estate deal for America” explained
- A month before the crash
- Trump Did WHAT??
Receive News & Ratings for Afya Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Afya and related companies with MarketBeat.com's FREE daily email newsletter.
